Goldmoney Inc. Announces Normal Course Issuer Bid

Stock Information for Sernova Biotherapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Sernova Biotherapeutics Inc.

Goldmoney Inc. Reports Results for the Quarter Ended September 30 2025
Goldmoney Inc. Announces Results of 2025 Annual Meeting of Shareholders
Goldmoney Inc. Announces Change of Auditor
Goldmoney Inc. Reports Results for the Quarter Ended June 30, 2025
Goldmoney Inc. Reports Fiscal Year 2025 Annual Results and Publishes Annual Letter to Shareholders
Goldmoney Inc. Reports Results for the Quarter Ended December 31, 2024; Announces Restatement of 2024 audited comparative Financial Statements
Goldmoney Inc. Announces Property Acquisition
Goldmoney Inc. Responds to Property Purchase Media Reports

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.